找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Aortic Root Surgery; The Biological Solut Charles A. Yankah (Professor of Surgery Consutant Book 2010 The Editor(s) (if applicable) and Th

[復(fù)制鏈接]
樓主: 要求
21#
發(fā)表于 2025-3-25 06:26:17 | 只看該作者
22#
發(fā)表于 2025-3-25 07:37:55 | 只看該作者
Using BioGlue to achieve hemostasis in aortic root surgerydrome who underwent aortic root replacement, 9% of patients required mediastinal reexploration to treat bleeding [.]. In another recent report, the incidence of bleeding requiring reoperation was 12.9% in a series of 132 patients who underwent root replacement with porcine aortic root xenografts [.].
23#
發(fā)表于 2025-3-25 12:16:54 | 只看該作者
24#
發(fā)表于 2025-3-25 19:28:54 | 只看該作者
25#
發(fā)表于 2025-3-25 20:43:23 | 只看該作者
Aortic annuloplastyy shortening the circumference of its annulus” [.]. However, in practical surgical situations, a valve annulus can either be enlarged or reduced. Accordingly, we will discuss reduction and augmentation aortic annuloplasty in this chapter.
26#
發(fā)表于 2025-3-26 00:24:45 | 只看該作者
Percutaneous transluminal aortic valve replacement: The CoreValve prosthesisith a single diseased valve were declined for surgery or were never considered as surgical candidates, due to an expected short life expectancy and associated comorbid conditions [.]. alternative techniques for treatment of high-risk patients are therefore needed.
27#
發(fā)表于 2025-3-26 08:15:29 | 只看該作者
From minimally invasive to percutaneous aortic valve replacement has shifted with the majority of diseased valves being replaced by a bioprosthesis today [.]. In contrast to coronary surgery where the decline in the number of operations has been accompanied by a rising procedural volume of percutaneous coronary interventions (PCI) since the late 1990s, valve sur
28#
發(fā)表于 2025-3-26 08:36:03 | 只看該作者
29#
發(fā)表于 2025-3-26 16:33:49 | 只看該作者
Yacoub/David techniques for aortic root operation: success and failuresith fibrous, elastic, nervous, and muscular properties [., ., .]. No such thin, but at the same time strong and non-thrombogeneic material can be produced in laboratories and even less by industrial processes.
30#
發(fā)表于 2025-3-26 19:20:53 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 04:37
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
洞口县| 藁城市| 宁化县| 雅江县| 麻栗坡县| 海阳市| 元谋县| 辽中县| 稷山县| 嘉善县| 甘南县| 翼城县| 五原县| 白玉县| 鹰潭市| 尚志市| 冀州市| 阿合奇县| 察隅县| 石渠县| 抚远县| 剑阁县| 平潭县| 迭部县| 樟树市| 南华县| 曲麻莱县| 开封县| 陇川县| 山西省| 卢氏县| 靖州| 吴江市| 田东县| 鹤庆县| 千阳县| 长汀县| 资溪县| 长乐市| 南漳县| 谷城县|